# LAMICTAL XR
> **NDA022509** · New Drug Application · Sponsor: SMITHKLINE BEECHAM · Approved 2010-01-29
## Drug
- **FDA Application Number:** NDA022509
- **Application type:** New Drug Application
- **Brand name:** LAMICTAL XR
- **Generic name:** Lamotrigine
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SMITHKLINE BEECHAM
- **First approval:** 2010-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022509)
---
*AI Analytics · CC0 1.0*